We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.95%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$8.49B
AUM Growth
-$96.8M
(-1.1%)
Cap. Flow
-$229M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
17.82%
Holding
2,013
New
45
Increased
399
Reduced
1,471
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$32.4M |
| 2 |
Amgen
AMGN
|
+$13.1M |
| 3 |
Medtronic
MDT
|
+$8.19M |
| 4 |
CELG
Celgene Corp
CELG
|
+$8.07M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$36.5M |
| 2 |
AGN
Allergan Inc
AGN
|
+$14.1M |
| 3 |
Microsoft
MSFT
|
+$10.4M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$9.41M |
| 5 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$8.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.26% |
| 2 | Technology | 16.97% |
| 3 | Financials | 14.32% |
| 4 | Communication Services | 7.87% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRI
1126
DELISTED
Albany Molecular Research Inc
AMRI
| $554K | 0.01% |
31,475
+4,312
| +16% | +$73.5K |
|
1127
Oshkosh
OSK
$9.67B
| $552K | 0.01% |
11,314
-1,978
| -15% | -$90.4K |
|
1128
Texas Roadhouse
TXRH
$12.7B
| $552K | 0.01% |
15,156
-1,418
| -9% | -$50.4K |
|
1129
Brinker International
EAT
$8.02B
| $551K | 0.01% |
8,957
-1,642
| -15% | -$98.8K |
|
1130
MillerKnoll
MLKN
$1.5B
| $551K | 0.01% |
19,853
-2,598
| -12% | -$76K |
|
|
FPRX
1131
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $551K | 0.01% |
24,115
+6,141
| +34% | +$155K |
|
|
OSIR
1132
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $551K | 0.01% |
31,318
+4,525
| +17% | +$76K |
|
1133
Sarepta Therapeutics
SRPT
$1.66B
| $546K | 0.01% |
41,145
+5,052
| +14% | +$67.3K |
|
|
CHMT
1134
DELISTED
Chemtura Corporation
CHMT
| $545K | 0.01% |
19,966
-6,259
| -24% | -$155K |
|
1135
Cimpress
CMPR
$2.37B
| $543K | 0.01% |
6,430
-717
| -10% | -$57.3K |
|
1136
Marvell Technology
MRVL
$174B
| $543K | 0.01% |
36,936
-9,572
| -21% | -$151K |
|
1137
Opko Health
OPK
$921M
| $539K | 0.01% |
38,073
-4,242
| -10% | -$55.2K |
|
|
JCP
1138
DELISTED
J.C. Penney Company, Inc.
JCP
| $539K | 0.01% |
64,078
-24,527
| -28% | -$191K |
|
|
SJI
1139
DELISTED
South Jersey Industries, Inc.
SJI
| $538K | 0.01% |
19,814
+800
| +4% | +$22.8K |
|
|
RVBD
1140
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $537K | 0.01% |
25,691
-5,158
| -17% | -$107K |
|
|
PETX
1141
DELISTED
Aratana Therapeutics, Inc.
PETX
| $536K | 0.01% |
33,507
+4,357
| +15% | +$77.5K |
|
1142
MSC Industrial Direct
MSM
$7.02B
| $530K | 0.01% |
7,346
-1,116
| -13% | -$83.3K |
|
1143
Theravance Biopharma
TBPH
$874M
| $529K | 0.01% |
30,512
+4,117
| +16% | +$75.5K |
|
1144
John Wiley & Sons Class A
WLY
$2.52B
| $529K | 0.01% |
8,650
+883
| +11% | +$54.2K |
|
1145
ITT
ITT
$17.5B
| $526K | 0.01% |
13,176
-5,322
| -29% | -$208K |
|
|
MGLN
1146
DELISTED
Magellan Health Services, Inc.
MGLN
| $526K | 0.01% |
7,425
-500
| -6% | -$31.5K |
|
1147
Leidos
LDOS
$14.1B
| $525K | 0.01% |
12,518
-3,307
| -21% | -$144K |
|
1148
Darling Ingredients
DAR
$9.93B
| $524K | 0.01% |
37,375
-2,857
| -7% | -$47K |
|
1149
Old National Bancorp
ONB
$10.1B
| $524K | 0.01% |
36,922
-3,174
| -8% | -$44.3K |
|
|
DST
1150
DELISTED
DST Systems Inc.
DST
| $524K | 0.01% |
9,464
-2,180
| -19% | -$112K |
|
Similar funds
ProShare Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, ProShare Advisors held 2,013 positions worth $8.49B, down 1.1% from $8.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors's Q1 2015 filing shows 45 new, 399 increased, 1,471 reduced and 95 closed positions. Its largest new stake was Qorvo: 60,564 shares worth $4.83M. The largest sale was Visa, an estimated $36.5M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- ProShare Advisors's largest Q1 2015 buy was Qorvo: 60,564 shares worth $4.83M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q1 2015, an estimated $32.4M increase.
- ProShare Advisors's biggest Q1 2015 reduction was Visa, cutting an estimated $36.5M.
- ProShare Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $14.1M.
- ProShare Advisors's ten largest holdings make up 18% of its $8.49B portfolio in Q1 2015.
- ProShare Advisors opened 45 new positions and closed 95 in Q1 2015.
- ProShare Advisors's portfolio value fell 1.1% quarter-over-quarter to $8.49B.
Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.